Part Details | OMEPRAZOLE EXTENDED-RELEASE CAPSULES
6505-01-611-1221
Alternate Parts: NDC62175011837, NDC62175-0118-37, 32251, 6505NCM127381, NDC62175011837, NDC62175-0118-37, NDC62175011837, NDC62175-0118-37, NDC00378615001, NDC00378-6150-01, NDC00781223301, NDC00781-2233-01, 6505-01-611-1221, 01-611-1221, 6505016111221, 016111221
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | SEP 06, 2012 | 01-611-1221 | 42777 ( OMEPRAZOLE EXTENDED-RELEASE CAPSULES ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-611-1221
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC62175-0118-37 | 1XUY5 | AMERISOURCEBERGEN DRUG CORPORATIONDIV CORPORATE OFFICE |
| 32251 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM127381 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NDC62175-0118-37 | 3JLW4 | GOLDEN STATE MEDICAL, INC |
| NDC62175-0118-37 | 6D0K6 | KREMERS URBAN PHARMACEUTICALS INC. |
| NDC00378-6150-01 | 3KJG9 | MYLAN PHARMACEUTICALS INC. |
| NDC00781-2233-01 | 0THL4 | SANDOZ INC. |
Technical Data | NSN 6505-01-611-1221
| Characteristic | Specifications |
|---|---|
| PRIMARY CONTAINER TYPE | BOTTLE |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.0 |
| SPECIAL FEATURES | 20 MG ACTIVE INGREDIENT; 100 CAPSULES PER BOTTLE |
| PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | OMEPRAZOLE EXTENDED RELEASE CAPSULES 20MG 100S |